Diet is increasingly recognized as a potential factor influencing MS pathophysiology.
Objective:
To examine associations between diet and clinical/imaging/laboratory biomarkers of MS-related burden.
Methods:
In this cross-sectional study, daily nutrient intake was quantified in 112 MS patients using the French MetaCardis food frequency questionnaire. Participants underwent matched serum and 3T brain magnetic resonance imaging (MRI), including brain volumetrics, brain-predicted age, cortical lesions (CL), central vein sign (CVS), paramagnetic rim lesions (PRLs), and enlarged perivascular space (EPVS) assessments. p-values were false discovery rate corrected (pFDR), and regression models adjusted for energy intake and potential confounders.
Results:
Participants (66% women, 72% relapsing-remitting MS) had a median age of 42 years (interquartile range (IQR) = 20), disease duration of 9 years (20), body mass index (BMI) of 22.8 (5.3) kg/m², and expanded disability status scale (EDSS) of 2 (2.5). Saturated and trans-fatty acids intake were positively associated with anxiety symptoms (β = 0.39, pFDR = 0.02; β = 13.09, pFDR = 0.03, respectively).Alcohol intake was positively associated with EPVS score (β = 0.02, pFDR = 0.01), whereas trans-fatty acid intake was positively associated with CL count (β = 17.50, pFDR = 0.04) and PRL volume (β = 3251.37, pFDR = 0.04).
Conclusion:
Higher intake of saturated and trans-fatty acids and alcohol was associated with biomarkers of chronic inflammation and neurovascular dysfunction, suggesting a potential role in MS progression. Longitudinal and interventional studies are needed to establish causality.
StoiloudisPKesidouEBakirtzisC, et al. The role of diet and interventions on multiple sclerosis: A review. Nutrients2022; 14(6): 1150.
2.
CorrealeJHohlfeldRBaranziniSE. The role of the gut microbiota in multiple sclerosis. Nat Rev Neurol2022; 18(9): 544–558.
3.
SwankRLDuganBB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet1990; 336(8706): 37–39.
4.
SaulATaylorBBlizzardL, et al. A pro-inflammatory diet is associated with long-term depression and anxiety levels but not fatigue in people with multiple sclerosis. Mult Scler Relat Disord2024; 84: 105468.
5.
SaulAMTaylorBVBlizzardL, et al. A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort study. Mult Scler2023; 29(8): 1012–1023.
6.
GuglielmettiMGrossoGFerrarisC, et al. Ultra-processed foods consumption is associated with multiple sclerosis severity. Front Neurol2023; 14: 1086720.
7.
WuJOlssonTHillertJA, et al. Association between alcohol consumption and disability accumulation in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm2024; 11(5): e200289.
8.
GędekAKoziorowskiDSzlufikS. Assessment of factors influencing glymphatic activity and implications for clinical medicine. Front Neurol2023; 14: 1232304.
9.
BorrelliSGuissetFVanden BulckeC, et al. Enlarged perivascular spaces are associated with brain microangiopathy and aging in multiple sclerosis. Mult Scler2024; 30(8): 983–993.
10.
CalabreseMPreziosaPScalfariA, et al. Determinants and biomarkers of progression independent of relapses in multiple sclerosis. Ann Neurol2024; 96(1): 1–20.
11.
ThompsonAJBanwellBLBarkhofF, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol2018; 17(2): 162–173.
12.
VergerEOArmstrongPNielsenT, et al. Dietary assessment in the MetaCardis Study: Development and relative validity of an online food frequency questionnaire. J Acad Nutr Diet2017; 117(6): 878–888.
13.
ShivappaNSteckSEHurleyTG, et al. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr2014; 17(8): 1689–1696.
14.
FarezMFFiolMPGaitánMI, et al. Sodium intake is associated with increased disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry2015; 86(1): 26–31.
15.
SimonettoMInfanteMSaccoRL, et al. A novel anti-inflammatory role of Omega-3 PUFAs in prevention and treatment of atherosclerosis and vascular cognitive impairment and dementia. Nutrients2019; 11(10): 2279.
16.
BeckATBrownGEpsteinN, et al. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol1988; 56: 893–897.
17.
LeahyJM. Validity and reliability of the beck depression inventory-short form in a group of adult bereaved females. J Clin Psychol1992; 48(1): 64–68.
18.
AbsintaMSatiPFechnerA, et al. Identification of chronic active Multiple Sclerosis lesions on 3T MRI. AJNR Am J Neuroradiol2018; 39(7): 1233–1238.
19.
BorrelliSMartireMSStöltingA, et al. Central vein sign, cortical lesions, and paramagnetic rim lesions for the diagnostic and prognostic workup of multiple sclerosis. Neurol Neuroimmunol Neuroinflamm2024; 11(4): e200253.
20.
FilippiMPreziosaPBanwellBL, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: Practical guidelines. Brain2019; 142(7): 1858–1875.
21.
BagnatoFSatiPHemondCC, et al. Imaging chronic active lesions in multiple sclerosis: A consensus statement. Brain. 2024; 147: 2913–2933.
22.
DereskewiczELa RosaFDos Santos SilvaJ, et al. FLAMeS: A robust deep learning model for automated multiple sclerosis lesion segmentation. medRxiv2025; 05: 25327707.
23.
SatiPOhJConstableRT, et al. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: A consensus statement from the North American imaging in multiple sclerosis cooperative. Nat Rev Neurol2016; 12(12): 714–722.
24.
GeurtsJJGRoosendaalSDCalabreseM, et al. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology2011; 76(5): 418–424.
25.
FischlBSalatDHBusaE, et al. Whole brain segmentation. Neuron2002; 33(3): 341–355.
26.
KooTKLiMY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med2016; 15(2): 155–163.
27.
WillettWCHoweGRKushiLH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr1997; 65(4Suppl): 1220S–1228S; discussion1229S.
28.
BagurMJMurciaMAJiménez-MonrealAM, et al. Influence of diet in Multiple Sclerosis: A systematic review. Adv Nutr2017; 8(3): 463–472.
29.
Mc GuireCPrinzMBeyaertR, et al. Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology. Trends Mol Med2013; 19(10): 604–613.
30.
RiccioPRossanoRLiuzziGM. May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach. Autoimmune Dis2011; 2010: 249842.
31.
AlatabSMaghbooliZHossein-NezhadA, et al. Cytokine profile, Foxp3 and nuclear factor-kB ligand levels in multiple sclerosis subtypes. Minerva Med2011; 102(6): 461–468.
32.
TrentiniAManfrinatoMCCastellazziM, et al. TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis. Mult Scler2015; 21(9): 1121–1130.
33.
JoscelynJKasperLH. Digesting the emerging role for the gut microbiome in central nervous system demyelination. Mult Scler2014; 20(12): 1553–1559.
34.
ZierfussBWangZJacksonAN, et al. Iron in multiple sclerosis—Neuropathology, immunology, and real-world considerations. Mult Scler Relat Disord2023; 78: 104934.
35.
JiaoWLinJDengY, et al. The immunological perspective of major depressive disorder: Unveiling the interactions between central and peripheral immune mechanisms. J Neuroinflammation2025; 22(1): 10.
36.
RossiSStuderVMottaC, et al. Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis. Neurology2017; 89(13): 1338–1347.
37.
HedströmAKHillertJOlssonT, et al. Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk. JAMA Neurol2014; 71(3): 300.
38.
AndersenCSøndergaardHBBang OturaiD, et al. Alcohol consumption in adolescence is associated with a lower risk of multiple sclerosis in a Danish cohort. Mult Scler2019; 25(12): 1572–1579.
39.
Diaz-CruzCChuaASMalikMT, et al. The effect of alcohol and red wine consumption on clinical and MRI outcomes in multiple sclerosis. Mult Scler Relat Disord2017; 17: 47–53.
40.
Gili-MinerMLópez MéndezJVilches ArenasA, et al. Esclerosis múltiple y trastornos asociados al consumo de alcohol: Mortalidad atribuible, prolongación de estancias y exceso de costes hospitalarios. Neurología2018; 33(6): 351–359.
41.
PakpoorJGoldacreRDisantoG, et al. Alcohol misuse disorders and multiple sclerosis risk. JAMA Neurol2014; 71(9): 1188–1189.
42.
AhlersKEKaraçayBFullerL, et al. Transient activation of microglia following acute alcohol exposure in developing mouse neocortex is primarily driven by BAX-dependent neurodegeneration: Microglia and developmental alcohol exposure. Glia2015; 63(10): 1694–1713.
43.
Alfonso-LoechesSUreña-PeraltaJMorillo-BarguesMJ, et al. Ethanol-Induced TLR4/NLRP3 neuroinflammatory response in microglial cells promotes leukocyte infiltration across the BBB. Neurochem Res2016; 41(1-2): 193–209.
44.
BorrelliSLeclercqSPasiM, et al. Cerebral small vessel disease and glymphatic system dysfunction in multiple sclerosis: A narrative review. Mult Scler Relat Disord2024; 91: 105878.
45.
GuissetFLolliVBugliC, et al. The central vein sign in multiple sclerosis patients with vascular comorbidities. Mult Scler2021; 27(7): 1057–1065.
46.
SchwarzSLewelingH. Multiple sclerosis and nutrition. Mult Scler J2005; 11(1): 24–32.
47.
MarrieRHorwitzRCutterG, et al. High frequency of adverse health behaviors in multiple sclerosis. Mult Scler2009; 15(1): 105–113.
48.
Pinhas-HamielOLivneMHarariG, et al. Prevalence of overweight, obesity and metabolic syndrome components in multiple sclerosis patients with significant disability. Eur J Neurol2015; 22(9): 1275–1279.
49.
MarrieRAReiderNCohenJ, et al. A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis. Mult Scler2015; 21(3): 318–331.
50.
TetteyPSimpsonSTaylorBV, et al. Vascular comorbidities in the onset and progression of multiple sclerosis. J Neurol Sci2014; 347(1-2): 23–33.
51.
MarrieRARudickRHorwitzR, et al. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology2010; 74(13): 1041–1047.
52.
AronsonKJCleghornGGoldenbergE. Assistance arrangements and use of services among persons with multiple sclerosis and their caregivers. Disabil Rehabil1996; 18(7): 354–361.
53.
HadgkissEJJelinekGAWeilandTJ, et al. The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis. Nutr Neurosci2015; 18(3): 125–136.
54.
SamaraACantoniCPiccioL, et al. Obesity, gut microbiota, and multiple sclerosis: Unraveling the connection. Mult Scler Relat Disord2023; 76: 104768.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
